Respiratory Syncytial Virus ICU Clinical Consumables
As part of the NHS preparations for Respiratory Syncytial Virus, two ICU clinical consumable products have been suspended: FDD5180 and FDB494.
This is to protect stockholding and allocate volumes as determined by the NHS England and NHS Improvement consumption model. It aims to ensure that trusts continue to have access to the consumables they need to provide patient care and to avoid unnecessary risks of stock shortages.
If you have a clinical requirement to order FDD5180 or FDB494, please escalate this to your COVID-19 Regional Leads. Please note, the request must be a clinical necessity.
ICN 1325 will be updated when the affected products are reinstated and available to order, or if any additional codes are affected.
NHS England and NHS Improvement supported by NHS Supply Chain are carefully managing the supply of key consumables. This is in response to the COVID-19 pandemic and preparing for the UK transition from the EU.
Ensuring all NHS trusts have equal access to key consumables required to provide patient care remains a top priority.
Where there is an exceptional increase in national demand for ICU products, they will be suspended with immediate effect. Any other product suspensions will be managed outside of this process via the normal route.
NHS England (NHSE) and NHS Improvement (NHSI)
NHS England has released a useful and informative resource for Local Procurement and Supplies teams to signpost clinical queries in relation to COVID-19. It provides links for Primary Care, Secondary Care, Community, Social Care and Ambulance Services with sections providing specific support and information by each individual clinical speciality.